1月29日——RHYTHM BIOSCIENCES LTD宣布与AGRF建立战略联盟关系。此次合作将推动Genetype服务的商业化规模扩张,加速该技术平台的量产应用进程。
通过整合双方在生物技术领域的专业优势,这一战略伙伴关系有望为精准医疗市场带来更高效的基因分型解决方案。合作将聚焦于技术转化与市场落地,构建从研发到商业化的完整产业链。
此次联盟标志着Rhythm Biosciences在推进分子诊断技术规模化应用方面迈出关键一步,为未来全球市场拓展奠定基础。
1月29日——RHYTHM BIOSCIENCES LTD宣布与AGRF建立战略联盟关系。此次合作将推动Genetype服务的商业化规模扩张,加速该技术平台的量产应用进程。
通过整合双方在生物技术领域的专业优势,这一战略伙伴关系有望为精准医疗市场带来更高效的基因分型解决方案。合作将聚焦于技术转化与市场落地,构建从研发到商业化的完整产业链。
此次联盟标志着Rhythm Biosciences在推进分子诊断技术规模化应用方面迈出关键一步,为未来全球市场拓展奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.